We are live on ! Find out more
AC

Athanor Capital Portfolio holdings

AUM $24.6M
1-Year Est. Return 2.49%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$657M
Cap. Flow
+$330M
Cap. Flow %
12.55%
Top 10 Hldgs %
27.83%
Holding
739
New
212
Increased
152
Reduced
137
Closed
216

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$42.2M
2
NBL
Noble Energy, Inc.
NBL
+$38.4M
3
VZ icon
Verizon
VZ
+$38.3M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$33.7M
5
PG icon
Procter & Gamble
PG
+$29.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.81%
2 Consumer Discretionary 18.66%
3 Technology 15.33%
4 Financials 10.62%
5 Communication Services 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
276
ResMed
RMD
$32.9B
$747K 0.03%
+4,359
New +$805K
TPTX
277
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$744K 0.03%
8,521
-5,625
-40% -$392K
BBIO icon
278
BridgeBio Pharma
BBIO
$13.4B
$733K 0.03%
19,534
-9,424
-33% -$297K
PRU icon
279
Prudential Financial
PRU
$40.4B
$725K 0.03%
+11,410
New +$750K
SNX icon
280
TD Synnex
SNX
$20.8B
$723K 0.03%
+10,318
New +$649K
SONO icon
281
Sonos
SONO
$1.85B
$722K 0.03%
47,550
+11,418
+32% +$168K
JACK icon
282
Jack in the Box
JACK
$253M
$719K 0.03%
9,066
+3,821
+73% +$307K
STAG icon
283
STAG Industrial
STAG
$7.15B
$715K 0.03%
+23,447
New +$740K
CORT icon
284
Corcept Therapeutics
CORT
$12.1B
$699K 0.03%
40,136
+12,241
+44% +$195K
PAAS icon
285
Pan American Silver
PAAS
$19.7B
$699K 0.03%
21,739
-27
-0.1% -$928
MAC icon
286
CALL
Macerich
MAC
$6.36B
$679K 0.03%
+100,000
New +$786K
PRSP
287
DELISTED
Perspecta Inc. Common Stock
PRSP
$678K 0.03%
+34,852
New +$735K
HLF icon
288
Herbalife
HLF
$1.24B
$670K 0.03%
14,368
-1,031
-7% -$50.6K
USNA icon
289
Usana Health Sciences
USNA
$272M
$669K 0.03%
9,078
+3,473
+62% +$279K
PCVX icon
290
Vaxcyte
PCVX
$8.75B
$667K 0.03%
+13,516
New +$538K
INTC icon
291
Intel
INTC
$534B
$665K 0.03%
12,835
+7,561
+143% +$393K
YETI icon
292
Yeti Holdings
YETI
$2.96B
$663K 0.03%
+14,626
New +$693K
FOLD
293
DELISTED
Amicus Therapeutics
FOLD
$650K 0.02%
46,025
-41,441
-47% -$604K
CHRS icon
294
Coherus Oncology
CHRS
$188M
$642K 0.02%
35,010
+3,418
+11% +$63.6K
MCY icon
295
Mercury Insurance
MCY
$5.65B
$638K 0.02%
15,415
EXPO icon
296
Exponent
EXPO
$3.23B
$634K 0.02%
8,800
+5,232
+147% +$416K
FNV icon
297
Franco-Nevada
FNV
$50B
$629K 0.02%
+4,508
New +$670K
ABMD
298
DELISTED
Abiomed Inc
ABMD
$629K 0.02%
+2,270
New +$654K
KURA icon
299
Kura Oncology
KURA
$996M
$626K 0.02%
20,418
-7,895
-28% -$174K
CXO
300
DELISTED
CONCHO RESOURCES INC.
CXO
$625K 0.02%
+14,172
New +$707K

Similar funds

Athanor Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Athanor Capital held 739 positions worth $2.63B, up 33% from $1.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Athanor Capital deployed $330M of net new capital in Q3 2020, opening 212 new positions and adding to 152 existing holdings. Its largest new stake was Noble Energy, Inc.: 3,933,934 shares worth $33.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was People Inc, an estimated $57.3M trimmed.

  • Athanor Capital's largest Q3 2020 buy was Noble Energy, Inc.: 3,933,934 shares worth $33.6M.
  • Athanor Capital added most to Microsoft in Q3 2020, an estimated $42.2M increase.
  • Athanor Capital's biggest Q3 2020 reduction was People Inc, cutting an estimated $57.3M.
  • Athanor Capital fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2020, selling an estimated $57.1M.
  • Athanor Capital's ten largest holdings make up 28% of its $2.63B portfolio in Q3 2020.
  • Athanor Capital opened 212 new positions and closed 216 in Q3 2020.
  • Athanor Capital's portfolio value rose 33% quarter-over-quarter to $2.63B.

Based on Athanor Capital's 13F filing for Q3 2020, filed 16 Nov 2020.